Profile
Jeffrey G.
Hesselberg is currently the Vice President-Regulatory & Quality Affairs at Castle Creek Biosciences, Inc. He previously worked as the Director-Regulatory Affairs at ICOS Corp.
from 1996 to 2007 and as the Vice President-Regulatory Affairs at GTx, Inc. He holds an MBA degree from the University of Washington and an undergraduate degree from the University of Wisconsin.
Jeffrey G. Hesselberg active positions
| Companies | Position | Start |
|---|---|---|
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | General Counsel | 2019-12-31 |
Former positions of Jeffrey G. Hesselberg
| Companies | Position | End |
|---|---|---|
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology Manufactures medications to treat inflammation and other serious diseases | General Counsel | 2007-03-31 |
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of small molecules for the treatment of cancer | General Counsel | - |
Training of Jeffrey G. Hesselberg
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology Manufactures medications to treat inflammation and other serious diseases | Health Technology |
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of small molecules for the treatment of cancer | Health Technology |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | Health Technology |
- Stock Market
- Insiders
- Jeffrey G. Hesselberg
















